163 related articles for article (PubMed ID: 29856464)
1. Alopecia Areata-like Hair Loss Accompanying Toxic Epidermal Necrolysis.
Mashima E; Sawada Y; Inoue A; Saito-Sasaki N; Yamaguchi T; Yoshioka H; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
Acta Derm Venereol; 2018 Oct; 98(9):906-907. PubMed ID: 29856464
[No Abstract] [Full Text] [Related]
2. Persistent and diffuse hair graying after recovery from alopecia totalis.
Hsu CC; Yang CC
Int J Dermatol; 2014 Jan; 53(1):e38-9. PubMed ID: 22591311
[No Abstract] [Full Text] [Related]
3. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
4. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
5. [Toxic epidermal necrolysis treated with intravenous immunoglobulins].
Corne P; Dereure O; Guilhou JJ; Jonquet O
Rev Med Interne; 2001 May; 22(5):491-2. PubMed ID: 11402525
[No Abstract] [Full Text] [Related]
6. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
Gilhar A; Paus R; Kalish RS
J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
[TBL] [Abstract][Full Text] [Related]
8. Putative therapeutic mechanisms of simvastatin in the treatment of alopecia areata.
Shin JM; Jung KE; Yim SH; Rao B; Hong D; Seo YJ; Kim CD; Lee Y
J Am Acad Dermatol; 2021 Mar; 84(3):782-784. PubMed ID: 32278796
[No Abstract] [Full Text] [Related]
9. Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases.
Jagadeesan S; Sobhanakumari K; Sadanandan SM; Ravindran S; Divakaran MV; Skaria L; Kurien G
Indian J Dermatol Venereol Leprol; 2013; 79(4):506-11. PubMed ID: 23760320
[TBL] [Abstract][Full Text] [Related]
10. Rare manifestation of hypereosinophilic syndrome: Diffuse-type hair loss with massive perifollicular eosinophils.
Suzuki H; Fukui R; Tabata N; Aiba S
J Dermatol; 2020 Jan; 47(1):61-63. PubMed ID: 31713896
[TBL] [Abstract][Full Text] [Related]
11. Type 1 interferon signature in the scalp lesions of alopecia areata.
Ghoreishi M; Martinka M; Dutz JP
Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
[TBL] [Abstract][Full Text] [Related]
12. Perinevoid alopecia: a case report and literature review.
Kimura H; Nagase K; Narisawa Y
Br J Dermatol; 2018 Oct; 179(4):969-970. PubMed ID: 29704462
[No Abstract] [Full Text] [Related]
13. Photo-induced toxic epidermal necrolysis caused by clobazam.
Redondo P; Vicente J; España A; Subira ML; De Felipe I; Quintanilla E
Br J Dermatol; 1996 Dec; 135(6):999-1002. PubMed ID: 8977728
[TBL] [Abstract][Full Text] [Related]
14. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
[TBL] [Abstract][Full Text] [Related]
15. Melanocytes: a possible autoimmune target in alopecia areata.
Trautman S; Thompson M; Roberts J; Thompson CT
J Am Acad Dermatol; 2009 Sep; 61(3):529-30. PubMed ID: 19700020
[No Abstract] [Full Text] [Related]
16. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Epitope Identification Screen and Its Potential Application to the Study of Alopecia Areata.
Lindestam Arlehamn CS; Paul S; Chun Wang EH; de Jong A; Christiano AM; Sette A
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S54-S56. PubMed ID: 29273108
[No Abstract] [Full Text] [Related]
18. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
20. Collapse of immune privilege in alopecia areata: coincidental or substantial?
Gilhar A
J Invest Dermatol; 2010 Nov; 130(11):2535-7. PubMed ID: 20944635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
